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Thi responsiveness to nephritogenic antigens determines
susceptibility to crescentic glomerulonephritis in mice
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Thi responsiveness to nephritogenic antigens determines susceptibility
to crescentic glomerulonephritis in mice. The pattern of glomerulonephri-
tis (GN) developing in response to a planted antigen (sheep anti-mouse
GBM globulin) was compared in two strains of mice which demonstrated
either a predominant Thi (C57BL/6) or Th2 (BALB/c) response to this
antigen. GN was induced with a subnephritogenic i.v. dose of sheep
anti-mouse GBM globulin in mice presensitized to sheep globulin. Sensi-
tized C57BL/6 mice showed pronounced cutaneous delayed-type hyper-
sensitivity (DTH) following the challenge with sheep globulin, low titers of
circulating anti-sheep globulin antibody and high interferon y (IFNy) and
low interleukin 4 (IL-4) production by splenic T cells, consistent with a
predominant Thi pattern of immune response. Sensitized BALB/c mice
did not develop DTH following cutaneous challenge with sheep globulin,
had higher circulating anti-sheep globulin antibody titers, and showed high
IL-4 and low IFNy production by splenic T cells compared with C57BL/6
mice, consistent with a predominant Th2 response. In C57BL/6 mice, GN
developing in response to sheep globulin exhibited a severe crescentic
pattern with prominent glomerular T cell and macrophage influx and
fibrin deposition. In vivo depletion with a monoclonal anti-CD4 antibody
demonstrated that this injury was T helper cell dependent. Treatment with
monoclonal anti-mouse IFNy antibody significantly reduced glomerular
injury and crescent formation and attenuated the cutaneous DTH re-
sponse. GN induced by the same protocol in BALB/c mice exhibited
pronounced glomerular IgG and complement deposition. Crescent for-
mation, fibrin deposition, and glomerular T cell and macrophage infiltra-
tion were significantly less than observed in C57BL/6 mice, and injury was
not T cell dependent in the effector phase. These data suggest that the
pattern of glomerular injury induced by a planted antigen can be
determined by the balance of T helper cell subset activation. A Thi
response induces a severe crescentic pattern of GN, which like cutaneous
DTH, is T helper cell and IFNy dependent.
Glomerular accumulation of T cells is frequently observed in
severe proliferative and crescentic forms of experimental glomer-
ulonephritis (GN). Their accumulation is antigen specific and
their capacity to produce macrophage migration inhibitory factor
provides functional evidence of their activation [1, 21. Increasing
evidence now suggests the potential for T cells to act as effectors
of glomerular injury. Sensitized T cells can localize in glomeruli
and initiate acute injury in response to a planted hapten [3]. T cell
transfer studies in anti-GBM GN [4] and immune complex GN in
rats [5] and in autoimmune anti-GBM in chickens [6] have
demonstrated the capacity of T cells to induce glomerular injury,
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and T cell depletion studies in rats developing anti-GBM GN
demonstrate a pivotal role for both CD4 and CD8 positive T cells
in glomerular crescent formation [7, 81.
T cells are also consistently observed in glomeruli of patients
with severe proliferative and crescentic forms of GN [9—12], which
frequently develop in the absence of detectable immunoglobulin
deposition [13]. In these forms of ON, the presence of T helper
cells in glomeruli is also closely correlated with macrophage influx
and fibrin deposition [11], suggesting the involvement of mecha-
nisms of injury akin to delayed type hypersensitivity (DTH).
The concept of T helper cell subsets arose from studies of
Mosmann and Coffman, who demonstrated different cytokine
profiles and effector functions in cloned T helper cells [14]. It is
now clear that subsets of T helper cells, characterized by different
patterns of cytokine production, can direct immune effector
responses that may result in different disease outcomes from
identical infective or antigenic challenges. DTH responses are
directed by the Thi subset, which is distinguished by its propensity
to produce interferon y (IFNy) and interleukin 2 (IL-2) following
antigen challenge [15]. This response is directed by IFNy [16] and
inhibited by IL-4 [17] and IL-b [18]. Th2 responses stimulate
immunoglobulin production by plasma cells and induce isotype
switching. This subset is characterized by its capacity to produce
IL-4 and IL-b [14]. IFNy inhibits Th2 responses [19].
The capacity of these different subsets to direct the immune
response and determine disease outcome in vivo has been dem-
onstrated in inbred strains of mice infected with parasites.
C57BL/6 mice infected with Leishmania major develop a protec-
tive response with features of DTH, high levels IFNy, and low
IL-4 production consistent with a Thi response [20, 21]. BALB/c
mice fail to develop protection, exhibit higher IgE production and
less DTH, and show a Th2 cytokine profile with high levels of IL-4
and low IFNy production. Inbred strains of mice have been
demonstrated to exhibit either Thi or Th2 cytokine profiles in
association with different disease outcomes with a variety of
parasitic or organ specific antigens [22]. BALB!c mice consistently
demonstrate a Th2 pattern whereas C57BL/6, BlO, D2, and
C3H/HeN mice demonstrate a Thi pattern suggesting that, at
least in mice, the T helper cell's subset predominance is geneti-
cally determined and antigen independent.
The association between glomerular T cell and macrophage
influx, fibrin deposition and crescent formation in human and
experimental GN suggests that severe crescentic glomerular injury
results from a Thi directed, DTH-like response to nephritogenic
antigens. This hypothesis would predict that Thi prone strains of
Huang et a!: Thi cells direct crescent formation in GN 95
mice should develop a severe crescentic pattern of injury with
glomerular T cell and macrophage accumulation. This pattern of
injury would be expected to be T cell dependent in the effector
phase and should attenuated by blocking IFNy in vivo. On the
other hand, Th2 prone strains should develop injury in which
glomerular IgG and complement deposition were prominent
features and T helper cell depletion would have little effect. The
current studies tested this hypothesis in Thi prone (C57BL/6) and
Th2 prone (BALB/c) mice using a model of crescentic GN
induced by a planted glomerular antigen (a suhnephritogenic dose
of sheep anti-mouse GBM globulin).
Methods
Animals
Male C57BL/6 mice and BALB!c mice at eight to ten weeks of
age were obtained from Monash University, Central Animal
Services, Clayton, Victoria, Australia.
Induction of anti-GBM GN
Anti-GBM globulin was prepared from serum of a sheep
immunized against a particulate fraction of mouse GBM by
absorption with mouse red blood cells and ammonium sulphate
precipitation, as previously described [23, 241. Mice were sensi-
tized to sheep globulin by s.c. injection of a total of 2 mg in 200 1d
of CFA (Sigma Chemical Co., St. Louis, MO, USA) in divided
doses in each flank. Ten days later, GN was initiated by i.v.
administration of 5 mg of sheep anti-mouse GBM globulin. This
dose did not induce proteinuria in nonimmunized mice.
Histological assessment of glomerular injury
Glomerular crescent formation. Kidney tissue was fixed in
Bouin's fixative, embedded in paraffin and 4 m tissue sections
were cut and stained with periodic acid-Schiff (PAS) reagent and
silver methenamine/Masson trichrome. Glomerular crescent for-
mation was assessed by an experienced histopathologist (XRH) in
a blinded protocol. Glomeruli were considered to exhibit crescent
formation when more than three layers of cells were observed in
Bowman's space. A minimum of 20 glomeruli were assessed to
determine the crescent score for each animal.
Functional assessment of glomerular injury
Proteinuria. Mice were housed individually in cages to collect
urine over the final 24 hours of each experiment. Urinary protein
concentrations were determined by a modified Bradford method,
adapted to a microtiter plate assay as previously described [25].
The 24-hour urinary protein excretion was calculated from the
24-hour urine volume and the urinary protein concentration.
Serum creatinine and creatinine clearance. Serum and urine
creatinine concentrations were measured by the alkaline picric
acid method using an autoanalyzer (Cobas Bio; Roche Diagnostic,
Basel, Switzerland). Creatinine clearance was calculated from the
serum and urine creatinine and the urine volume.
Assessment of immunological effectors in glomeruli
Glomerular T cell and macrophage accumulation. Spleen and
kidney tissue was fixed in periodate lysine paraformaldehyde
(PLP) for four hours, washed in 7% sucrose solution then frozen
in liquid nitrogen cooled isopentane. Tissue sections (6 jsm) were
stained to demonstrate macrophages and T cells using a three
layer immunoperoxidase technique, as previously described [7,
24]. The primary antibodies were GKI.5 (monoclonal anti-mouse
CD4; ATCC, Rockville, MD, USA) and M1/70 (monoclonal
anti-mouse Mac-i; ATCC). Sections of spleen provided a positive
control for each animal and protein G purified rat immunoglob-
ulin was substituted for primary monoclonal antibody to provide a
negative control. A minimum of 20 equatorially sectioned glomer-
uli per animal were assessed per animal and the results were
expressed as cells per glomerular cross section (c/gcs).
Immunoglohulin, complement and fibrin. Tissue sections (4 jIm)
were cut from snap frozen kidney and stained by direct immun-
ofluoresence with FITC-conjugated sheep anti-mouse IgG
(Silenus; Hawthorn, Victoria, Australia), FITC-conjugated goat
anti-mouse C3 (Cappel, Durham, NC, USA) and FITC conju-
gated goat anti-rat fibrinogen (Nordic, Drawer, CA, USA), which
cross reacts with mouse fibrinogen. Semiquantitative assessment
of the glomerular deposition of these inflammatory mediators was
performed by determining the end point positive titer for detec-
tion of staining of these antigens using serial dilutions of each
antibody.
Assessment of the systemic immune response
Circulating mouse anti-sheep globulin antibody. Titers of mouse
anti-sheep globulin antibody were measured by ELISA on serum
collected at the end of each experiment. Round bottom polysty-
rene microtiter plates (Greiner Labortechnik, Germany) were
coated with 10 jig/mI normal sheep globulin in carbonate/bicar-
bonate buffer pH 9.5 by incubation overnight at 4°C, and then
blocked with 1% BSA. Plates were washed with PBS containing
0.1% Tween 20, then incubated with serial doubling dilutions of
mouse serum. After further washing, bound mouse immunoglob-
ulin was detected with horseradish peroxidase conjugated rabbit
anti-mouse IgG (Sigma) at a dilution of I in 4000 using 0.1 M
2,2'-azino-di-3-ethylbenzthiazoline sulphonate (ABTS; Boehr-
inger Mannheim, Germany) in 0.02% H202 as a substrate. The
reaction was stopped with of 0.1 M citric acid/0.01 % sodium azide
and the absorbance at 405 nm was read on a microtiter plate
reader (Dynatech Laboratories, Chantilly, VA, USA). Serum
from each mouse was tested at doubling dilutions, starting from a
dilution of 1 in 100 and serum from 6 non-immunized mice was
tested to provide normal controls.
Delayed type hypersensitivity to sheep globulin. Mice were chal-
lenged 24 hours prior to the end of each experiment by intrader-
mally injection of sheep globulin (50 jig in 30 j.tl of PBS) into the
plantar surface of a hindfoot. An irrelevant antigen (horse
globulin) was injected in the opposite foot pad as a control. DTH
was quantified 24 hours later by measuring footpad swelling using
a micrometer and histological appearances of DTH in the lesions
were confirmed on tissue sections stained with hematoxylin and
eosin.
Measurement of splenic T cell IFNY and IL-4 production
Spleens from sensitized mice were removed aseptically 24 hours
following the challenge with anti-GBM globulin and placed in
RPMI 1640 medium. Single cell suspensions were prepared by
gently teasing tissue apart and erythrocytes were lysed by incuba-
tion in Boyle's solution (0.17 M Tris, 0.16 M ammonium chloride)
for three minutes at 37°C. Cell suspensions were washed in RPMI
1640, then enriched for T cells by passage through nylon wool
column. Enriched T cells (5><106 cells/mi in RPMI 1640) were
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incubated for 48 hours at 37°C, 5% CO2 in 96-well flat-bottomed
tissue culture plates, and then the culture supernatants were
collected and stored at —70°C.
IFNy and IL-4 concentrations in supernatants from cultured T
cells were measured by ELISA. To measure IL-4, round bottom
polystyrene microtiter plates (Greiner Labortechnik, Germany)
were coated with monoclonal rat anti-mouse IL-4 mAb (11BI 1;
ATCC) at a concentration of 5 gJml and were then blocked with
1% BSA. Culture supernatant (100 .tl) and recombinant IL-4
standards were incubated in wells for two hours at 37°C. Biotin-
ylated anti-mouse 1L4 mAb (BVD6; DNAX, Palo Alto, CA,
USA) was used as the detecting antibody at a concentration of 2
g/ml. The plates were washed and then incubated with goat
anti-biotin peroxidase conjugated antibody, at dilution of 1 in
4000. ABTS substrate solution was then added and the reaction
was stopped after 10 minutes with 0.1 M citric acid containing
0.1% sodium azide (Ajax, Australia) and the absorbance read at
405 nm on an ELISA plate reader. Supernatants were assayed for
IFN7 using a commercial ELISA (InterTest-y, Mouse IFNy
ELISA; Genzyme).
T helper cell depletion protocols
T helper cell depletion was induced by a single intravenous
injection of 2 mg per mouse of protein G purified rat anti-mouse
CD4 monoclonal antibody (GK 1.5), administered 24 hours after
injection of anti-GBM globulin. This antibody has been previously
established to produce prolonged T helper cell depletion in vivo
[26—28]. The extent of T cell depletion in blood was assessed by
flow cytometry and in spleen by immunohistochemistry on day 10
of the disease using anti-CD3 monoclonal antibody (30H/12,
ATCC) as a pan T cell marker and GKI.5 to detect CD4 positive
cells.
Modification of the immune response by anti-IFNy antibody
treatment
Monoclonal anti-IFNy antibody (R4-6A2) [26] was adminis-
tered to C57BL16 mice at the time of initial antigen sensitization
and at the time of disease initiation, in order to functionally
inhibit the effects of IFNy in vivo and redirect the immune
response towards a Th2 response. This strategy has been previ-
ously employed in other murine disease models including Leish-
maniasis [29] and experimental allergic encephalitis [30] and
collagen induced arthritis [31]. Mice were given 1 mg of protein G
purified immunoglobulin i.p., two hours prior to sensitization with
sheep globulin in CFA, and 1.0 mg i.p. two hours prior to
administration of sheep anti-mouse GBM globulin and 0.5 mg on
days 3 and 7 after anti-GBM globulin. Glomerular injury, circu-
lating anti-sheep globulin titers and the cutaneous DTH response
to sheep globulin were assessed 10 days after initiation of anti-
GBM GN as detailed above.
Experimental design and statistical analysis
Anti-GBM GN was induced as described above in C57BL/6 and
BALB/c mice and glomerular injury was assessed 10 days after
administration of anti-GBM antibody. The effect of in vivo CD4 T
cell depletion on the development of anti-GBM GBM was studied
in both strains on day 10. The effect of in vivo inhibition of IFN by
administration of anti-IFNy antibody was studied in C57BL/6
mice developing anti-GBM GN on day 10. Control mice were age
and sex matched with experimental mice.
Groups consisted of 6 to 8 mice and the results are expressed as
the mean SEM. The statistical significance of differences be-
tween groups was determined by the Mann Whitney U-test.
Results
Characterization of the immune response to sheep globulin in
C57BLI6 and BALB/c mice
Cutaneous DTH. C57BL/6 mice exhibited a marked DTH
response with significant footpad swelling following the challenge
with sheep globulin (3.0 0.01 mm, normal 1.8 0.01 mm, P <
0.01). Challenge with horse globulin in the contralateral footpad
did not result in swelling (1.8 0.01 mm). In BALB/c mice,
significant skin swelling was not observed following antigen chal-
lenge (footpad swelling, 2.0 0.01 mm, horse globulin control
1.8 0.05 mm).
Circulating mouse anti-sheep globulin antibody titers. (Fig. 1)
BALB/c mice developed higher anti-sheep globulin antibody titers
in their serum than C57BL/6 mice.
Splenic cytokine production. (Fig. 2) The profile of cytokine
production by splenic T cells was markedly different in C57BL16
and BALB/c mice. Splenic T cells from C57BL/6 mice produced
significantly more IFNy (180 17.3 pg/b5 cells/48 hr) than those
from BALB/c mice (40.6 11.6 pg/105 cells/48 hr, P < 0.05). IL-4
production by splenic T cells showed a reciprocal pattern to IFN7
with higher levels in BALB/c mice (38.2 6.4 pg/b5 cells/48 hr)
than in C57BL/6 mice (10 1.0 pg/105 cells/48 hr, P < 0.05).
Neither IFNY nor IL-4 production were detectable in superna-
tants of splenic T cells from normal mice.
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Fig. 1. Serum titers of anti-sheep globulin antibody in mice with anti-GBM
GN. Mouse anti-sheep globulin antibody titers were assayed by ELISA in
serial doubling dilutions of serum. Untreated C57BLIÔ mice (S) with GN
demonstrated lower antibody titers than BALB/c mice (•). T helper cell
depletion of sensitized C57BL/6 (0) or BALB/c mice (0) did not alter
antibody levels. Treatment of C57BL/6 mice with anti-IFNg antibody (A)
also did not effect antibody titers. The titration for serum from unimmun-
ised C57BL/6 (O) and BALB/c (•) mice is also shown.
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Manifestation of GN in response to sheep globulin
Histological pattern (Fig. 3) and cellular infiltrate (Table 1).
C57BL/6 mice developed a severe proliferative and crescentic GN
after challenge with anti-GBM antibody (Fig. 3C). Glomeruli
were hypercellular and contained a prominent glomerular mac-
rophage infiltrate (Fig. 3E) with 8.5 0.8 c/gcs (normal 0.01
0.00 1 c/gcs, P < 0.001), together with a significant influx of CD4
positive T cells (2.0 0.1 c/gcs, normal 0.01 0.01/gcs; P < 0.001;
Fig. 3G). Segmental thrombosis and necrosis in capillary loops
was not a prominent feature, being observed in 10.1 2.9% of
glomeruli. Peri-glomerular inflammatory infiltration was promi-
nent, particularly around crescentic glomeruli.
In contrast to C57BL/6 mice, glomeruli of BALB/c mice
exhibited uniform expansion of mesangial matrix and capillary
walls appeared thickened, irregular and often showed splitting
and adhesion to Bowman's capsule. Obliteration of capillary loops
with segmental and lobular thrombosis was observed in 80 2.2%
of glomeruli (Fig. 3D). Some glomeruli demonstrated necrosis or
global sclerosis. Glomerular hypercellularity was noticably re-
duced compared to C57BL!6 mice. Accumulation of CD4-positive
T cells (Fig. 3H; 0.5 0.01 c/gcs, normal 0.01 0.001 c/gcs) and
macrophages (Fig. 3F; 2.0 0.1 c/gcs, normal 0.01 0.001 c/gcs)
was significantly less than in C57BL16 mice (P < 0.00 1 in each
case).
Humoral immune effectors in glomeruli (Table 1). The nephrito-
genie antigen (sheep globulin) was evident in glomerular capillary
loops in both strains of mice. There was no difference in the
Thi prone mice
(C57BL/6)
Th2 prone mice
(BALB/c)
CD4 positive T cells clgcs 2.0 0.1 0.5 0.01
Macrophages c/gcs 8.5 0.8 2.0 0.1
Mouse immunoglobulin
end point titer"
sparse
I in 600
strong linear
1 in 1200
Complement sparse strong linear
end point titer I in 500 1 in 1500
Fibrin 6 of 6 mice 2 of 6 mice
end point titer 1 in 50 1 in 10
Crescents % of glomeruli 41 2.3 10 2.0
glomerular binding of this antigen in the two strains of mice as
assessed by the mean immunofluoresence end point titer required
for its detection. However, the deposition of autologous mouse
antibody was markedly different between the two strains. Intense
linear deposition of mouse IgG was seen in glomerular capillary
loops in BALB/c mice (mean end point titer for detection by
immunofluoresenee, 1:1200; Fig. 4B), while only weak and sparse
antibody deposition was seen in C57BL16 mice (mean end point
titer for detection by immunofluoresence, 1:600; Fig. 4A). A
similar difference between the two strains was noted for glomer-
ular C3 deposition. Intense linear deposition of C3 was observed
in glomerular capillary loops of BALB!c mice (end point titer for
detection by immunofluoresence, 1:1500 dilution; Fig. 4D), and
sparse glomerular deposition was detected in C57BL/6 mice (end
point for detection by immunofluoresenee, 1:500; Fig. 4C).
Glomerular crescent formation and fibrin deposition. C57BL16
mice developed prominent glomerular crescent formation. Cres-
cents were present in 41 2.3% of glomeruli, but were never
present in normal mice. BALBIc mice showed significantly less
propensity to crescent formation (10 2.0% of glomeruli af-
fected, P < 0.001) than C57BL!6 mice.
Glomerular fibrin deposition was observed in all CS7BL/6 mice
with anti-GBM GN (Fig. 4E). In these mice, fibrin deposits were
detectable either within Bowman's space or within glomerular
tufts, in greater than 50% of glomeruli at an anti-fibrin antibody
titer of I in 50. Fibrin deposition oceured most frequently in the
glomerular tuft. In BALB/c mice, glomerular fibrin deposits were
generally absent (Fig. 4E). Sparse, focal and segmental deposition
of fibrin in the glomerular tuft was detectable in only 2 of 6 mice
(in approximately 15% of glomeruli) using an anti-fibrin antibody
titer of I in 10. Fibrin deposits were not observed in Bowman's
space.
Proteinuria, serum creatinine and creatinine clearance. Develop-
ment of GN in both C57BL/6 and BALB/e was associated with
marked proteinuria, increased serum ereatinine and reduced
creatinine clearance. In C57BL/6 mice, proteinuria was 7.6 1.2
mg/24 hr (normal 0.4 0.1 mg/24 hr, P < 0.01), serum creatinine
was 69 5.5 JLmol/liter (normal 29 1.0 .rmol/liter, P < 0.01)
and creatinine clearance was 8.3 0.8 1.d/min (normal 68.9 4.7
p.1/mm, P < 0.001). In BALB/c mice, protcinuria was 8.4 1.0
mg/24 hr (normal 1.2 0.3 mg/24 hr, P < 0.01), serum creatinine
was 65.6 8.3 p.mol/liter (normal 30.3 1.4 p.mol/liter,P <0.01)
Table 1. Comparison of immune efléctors in glomeruli in Thi and Th2
prone mice with anti-GBM GN
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Fig. 2. Profile of cytokine production by splenic T cells from CS7BL/6 and
BALB/c mice stimulated with sheep globulin in vitro. C57BL/6 mice show a
Th 1 profile with high IFNy and low IL-4 production when compared with
BALB/c mice which show a Th2 profile with low IFNy and high IL-4
production.
Glomerular T cell and macrophage numbers are presented as cells per
glomerular cross-section.
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Fig. 4. Humoral mediators of glomerular injuly in Thi and Th2 strains of mice with anti-GBM GN demonstrated by immunofluorescence. Thi prone
C57BL/6 mice exhibited weak glomerular deposition of mouse immunoglobulin (A) and complement (C), whereas a strong linear pattern of
immunoglobulin (B) and complement (D) deposition was observed in BALB/c mice. In contrast, fibrin deposition in the glomerular tuft and Bowman's
space was prominent in C57BL/6 mice (E) and generally absent in BALB/c mice (F). Magnification X400 in all panels.
Fig. 3. Histological patterns of glomerular injuly in Thi and Th2 strains of mice with anti -GBM GN. Thi prone C57BL/6 mice exhibited a proliferative,
crescentic GN (C, silver methionine/Mason trichrome stain, crescent indicated by arrow) with prominent glomerular macrophage infiltration (arrowed)
within and surrounding the glomerular tuft (E, immunoperoxidase using M1/70) and CD4 positive T cells (arrowed, G, immunoperoxidase using GKI.5).
BALB/c mice showed diffuse mesangial expansion and obliteration of many capillary loops and no hypercellularity (D), with sparse glomerular
macrophage (F) and T helper cell infiltration (H). The appearances of normal C57BL/6 (A, silver methenamine/Mason trichome stain) and BALB/c
mouse glomeruli (B) are indistinguishable histologically. Magnification x400 in all panels.
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and creatinine clearance was 7.5 1.8 p.1/mm (normal 65.9 4.4
1u1/min, P < 0.001).
Effect of T cell depletion on glomerular injury
Effect on circulating T cells. The role of CD4 positive T helper
cells as effectors on glomerular injury was compared in both
C57BL/6 and BALB/c mice, by in vivo depletion using a mono-
clonal rat anti-mouse CD4 antibody. A single dose of antibody,
given 24 hours after administration of anti-GBM globulin, re-
sulted in prolonged depletion of circulating CD4 positive T cells,
in both strains of mice. Twenty-four hours after anti-CD4 anti-
body treatment, CD3 positive cells were significantly reduced to
12.8 0.6% (normal 56.5 1.7%, P < 0.001) and CD4 positive
cells to 9.5 0.6% (normal 47.0 2.0%, P < 0.001) of total
circulating leukocytes in C57BL/6 mice and to 12.0 0.8%
(normal 54.3 1.9%) and 9.0 0.5% (normal 45.5 2.7%),
respectively, in BALB/c mice (both also P < 0.001 compared to
normal). Ten days after anti-GBM globulin, CD3 positive cells
were 9.8 0.8% and CD4 positive cells 2.6 0.5% of total
circulating leukocytes in C57BL/6 mice (both P <0.001 compared
to normal) and 11.3 1.0% and 3.1 0.6%, respectively, in
BALB/c mice (both P < 0.001 compared to normal).
Effect on circulating anti-sheep globulin titers and cutaneous
DTH. Treatment with anti-CD4 antibody did not alter the serum
titers of anti-sheep globulin in either C57BL/6 or BALB/c mice
(Fig. 1); however, the cutaneous DTH response to sheep globulin
in C57BL/6 mice was suppressed (footpad thickness following
challenge in treated mice 2.0 0.05 mm, untreated mice 3.0
0.01 mm, P < 0.01).
Effect on glomerular injury. The helper cell depletion signifi-
cantly reduced histological manifestations of GN in C57BL16 mice
(Fig. 5B). Compared with control antibody treated mice (Fig. 5A),
CD4 positive T cell and macrophage infiltration were both
significantly reduced by treatment with anti-CD4 antibody. Cres-
cent formation was significantly reduced (4.8 1.0% of glomeruli,
control 37 2.5%, P < 0.01) and fibrin deposition was observed
sparsely in 10% of glomeruli. Proteinuria was also significantly
reduced (2.4 0.1 mg/24 hr, control 7.6 0.1 mg/24 hr, P < 0.01).
Serum creatinine was significantly reduced (P < 0.01) and creat-
mine clearance was significantly higher (P < 0.01) in T cell
depleted mice compared to control mice indicating preservation
of renal function (Table 2).
In BALB/c mice, similar T cell depletion did not attenuate the
histological manifestations of GN (Fig. 5D), significantly reduce
proteinuria or preserve renal function. The minor incidence of
glomerular crescent formation observed in this strain was reduced
by T cell depletion to levels similar to those observed in T cell
depleted C57BL/6 mice (Table 2).
Anti-IFNy antibody treatment of anti-GBM GN
Effect on circulating immunoglobulin and cutaneous DTH. Treat-
ment of C57BL/6 mice with anti-IFNy antibody did not signifi-
cantly attenuate the serum titers of anti-sheep globulin antibody
(Fig. 1). However, cutaneous DTH following intradermal chal-
lenge with sheep globulin was abrogated (treated mice 1.70 0.01
mm, control antibody treated mice 2.84 0.03 mm, P < 0.01;
Table 3).
Effect on development of anti-GBM GN. Treatment with anti-
IFNy antibody attenuated the histological manifestations of GN
in C57BL/6 mice (treated Fig. 5F, control Fig. 5E; Table 3).
Glomerular T cell accumulation was unaffected but macrophage
recruitment was significantly reduced. Crescent formation was
significantly reduced (treated 4.0 1.4% of glomeruli, control
treated 40 3.0% of glomeruli, P < 0.01) as was proteinuria
(treated 2.5 0.6 mg/24 hr, control treated 6.0 0.6 mg/24 hr,
P < 0.01). Sparse fibrin deposition was detectable in less than
10% of glomeruli after anti-IFNy antibody treatment.
Discussion
Most cases of GN in humans appear to be immunologically
initiated. Many endogenous and exogenous antigens have been
implicated, however, in the majority of cases the antigens are
unknown. The immune response to nephritogenic antigens may
result in localization of immunoglobulin and/or recruitment of
sensitized T cells and result in a variety of histological patterns of
GN with a spectrum of functional outcomes from proteinuria or
hematuria with normal renal function through to severe rapidly
progressive crescentic injury and renal failure. The determinants
of these different outcomes remain unknown.
In the current studies, the contribution of T cell subsets to the
type of immune response and pattern of glomerular injury evoked
by a nephritogenic antigen was explored in inbred strains of mice.
GN was induced by planting an exogenous antigen (sheep globu-
lin) in glomeruli of sensitized mice using sheep anti-mouse GBM
globulin. The dose of anti-GBM globulin was chosen such that it
did not induce injury de novo in non-sensitized animals (a
subnephritogenic dose). In sensitized mice, this antigen initiated
an immune response in glomeruli which resulted in severe renal
injury. Similar severe glomerular injury has been induced in other
species using other 'planted' antigens including cationized BSA
[32] and lectins such as concanavalin A [33], demonstrating that
the capacity of exogenous antigens to induce glomerular injury is
not antigen or species specific.
Two inbred strains of mice, which have been previously dem-
onstrated to develop predominantly either a Thi or Th2 response
to a variety of antigens [20—221, were studied. C57BL/6 mice
produced a strong skin DTH response and a splenic T cell
cytokine profile characteristic of a Thi response following sensi-
tization and challenge with sheep globulin. BALB/c mice, how-
ever, did not develop a detectable skin DTH response to sheep
globulin and their splenic T cell cytokine pattern was indicative of
a Th2 response to this antigen. Higher levels of circulating
anti-sheep globulin antibodies in BALB/c mice also suggested that
these mice produced predominantly a Th2 response. Therefore,
the previously demonstrated predominance of Thi responses in
C57BL/6 mice and Th2 responses in BALB/c mice to parasitic and
other antigens was also observed with the antigen used to initiate
GN in the current studies.
Using identical sensitization and challenging protocols, the
glomerular lesions produced in the two strains were quite differ-
ent. C57BL/6 mice developed a severe proliferative and crescentic
pattern of GN with marked impairment of renal function, indi-
cated by increased proteinuria and serum creatinine. The marked
accumulation of T cells, macrophages and prominent fibrin dep-
osition suggested that DTH like effector mechanisms induce
glomerular injury in this strain. In vivo treatment of these mice
with monoclonal anti-CD4 antibody depleted circulation CD4 and
CD3 bearing T cells and, more importantly, markedly inhibited
their glomerular accumulation in response to the nephritogenic
antigen. The timing of T cell depletion allowed this to be achieved
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Fig. 5. Effect of T helper cell and interferony depletion on the histological appearance of anti-GBM GN. T helper cell depletion markedly attenuated the
histological features of injuiy in Tb] prone C57BL/6 mice (A, control treated; B, anti-CD4 antibody treated) but failed to alter the histological pattern in Th2
prone BALB/c mice GN (C, control treated; D, anti-CD4 antibody treated). In Thi prone C57BL/6 mice depletion of IFN also markedly attenuated the
glomerular injury (E, control treated; F, anti-IFNy antibody treated). Silver methenamine/Masson trichrome stain, magnification ><400 in all panels.
without altering the humoral immune response. Circulating levels
and glomerular deposition of autologous antibody were unaf-
fected in T helper cell depleted mice. However, crescent forma-
tion, macrophage influx and fibrin deposition were significantly
attenuated. At the same time, skin DTH was also abrogated
confirming that cutaneous DTH and by implication glomerular
DTH, were dependent on the local influx of antigen specific CD4
bearing T effector cells.
BALB/c mice developed a quite different pattern of glomerular
injury. However, in common with the C57BL/6 mice, this lesion
was also associated with severe renal injury, indicated by marked
proteinuria and increased serum creatinine. In BALBIc mice,
injury was characterized by enhanced production of mouse anti-
sheep globulin antibody and more pronounced glomerular depo-
sition of mouse globulin and complement. Significantly fewer T
cells and macrophages were observed in glomeruli and the
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Table 2. Effect of T helper cell depletion on DTH and anti-GBM GN
in Thi and Th2 prone mice
Anti-CD4 treated Thi Anti-CD4 treated Th2
DTH hind paw 2.0 0.05 (3.0 0.01) 2.0 0.01 (2.0 0.01)a
swelling-mm
Glomerular T cells 0.02 0.01 (2.0 0.1) 0.01 0.01 (0.01 0.01)
c/gcs
Glomerular macro- 1.5 0.1 (8.0 0.5) 0.05 0.01 (0.1 0.01)
phages c/cgs
Proteinuria mg/24 h 2.4 0.1 (7.6 0.1) 7.5 0.2 (7.8 0.2)
Crescents % glomeruli 4.8 1.0 (37 2.5) 4.2 1.0 (9.6 0.5)
Creatinine clearance 47 2.1 (60 5.00) 15 1.0 (12 1.0)
pi/min
a Numbers in parentheses represent the values for control antibody-
treated mice
histological pattern of glomerular injury was quite different. Their
glomeruli showed obliteration of capillary loops and uniform
mesangial expansion with PAS positive material. In comparison to
C57BL/6, these glomeruli were not hypercellular, had sparse
fibrin deposition and infrequently developed crescents. These
features in BALB/c mice suggest predominance of antibody
dependent, complement-mediated glomerular injury.
The low incidence of crescents observed in BALB/c mice
indicates either that prominent glomerular immunoglobulin dep-
osition can also drive crescent formation, or that this strain
develops some glomerular DTH, albeit markedly attenuated
compared to C57BL/6 mice. BALBIc mice demonstrated some
glomerular macrophage and T cell accumulation and their low
incidence of crescents was further reduced by T helper cell
depletion. Therefore, despite their inability to develop measur-
able cutaneous DTH, it is likely they still exhibit some glomerular
DTH to sheep globulin.
IFNy is essential for expansion of Thi T cell clones in vitro [16,
19] and in a number of disease models with features of DTH, in
vivo inhibition of IFNY alters the manifestations of injury [29—31,
34, 35] and has been used to provide evidence for the participation
of Thi effector cells. The capacity of anti-IFNy antibody to
prevent crescent formation and injury in C57BL!6 mice further
indicates that this glomerular lesion is ThI dependent. Blocking
IFNy was associated with marked attenuation of glomerular
macrophage recruitment with minimal effects on glomerular T cell
numbers, indicating that recruitment and activation of macro-
phages via T helper cell and IFNY dependent mechanisms plays a
critical role in crescent formation in this disease.
In summary, the current studies have shown that immune
responses to a planted glomerular antigen in animals with a
predominant Thi response to the challenging antigen, results in
glomerular DTH and crescent formation. GN induced in mice
with a predominant Th2 response to the planted glomerular
antigen shows a distinctly different histological pattern of glomer-
ular injury, with prominent glomerular immunoglobulin and com-
plement deposition. These studies both confirm an important role
for DTH in glomerular crescent formation, and show for the first
time that T helper subsets are likely to be an important determi-
nant of the outcome in glomerulonephritis. Advances in molecu-
lar immunology offer the potential to target selected components
of the immune response with antibodies to T cell subsets and
co-stimulatory molecules, and by blocking or administering cyto-
kines and growth factors. Inhibition of IFNy using soluble recep-
Table 3. Effect of anti-IFN7 antibody treatment in anti-GBM GN in
Thi prone mice
DTH hind paw swelling-mm 1.70 0.01 2.84 0.03
Glomerular T cells c/gcs 1.5 0.1 1.8 0.1
Glomerular macrophages c/gcs 2.2 0.1 8.2 0.5
Crescents % glomeruli 4.0 1.4 40 3.0
Proteinuria mg/24 h 2.5 0.6 6.0 0.6
Creatinine clearance p1/mm 48.6 2.8 10 1.0
tors or specific immunoglobulin has already been shown to alter
the outcome of GN in 'lupus prone' mice [36]. The current
experiments suggest that the results of such specific therapies in
GN may be quite varied, and a knowledge of the type of immune
response and the effector pathways involved may greatly facilitate
planning of suitable therapeutic strategies.
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